Journal Title：Medical Letter On Drugs And Therapeutics

The Medical Letter, Inc. is committed to providing objective, practical, and timely information on drugs and treatments of common diseases to help our readers make the best decisions for their patients—without the influence of the pharmaceutical industry.

The Medical Letter On Drugs and Therapeutics is a biweekly publication that provides:

Evidence-based, peer-reviewed evaluations of new FDA-approved drugs with conclusions reached by a consensus of experts

New information on previously approved drugs including pivotal clinical trials, new indications, and safety warnings

Consensus recommendations for the preferred and alternative treatments for common disorders

Comparative reviews of drugs for a given indication with particular attention to clinical efficacy, adverse effects, drug interactions, and cost.

《醫學快報》致力于提供客觀、實用、及時的常見疾病藥物和治療信息，幫助我們的讀者為患者做出最佳決策，不受制藥行業的影響。

《醫學快報：藥物和治療學》是一份雙周刊，提供：

基于證據、同行評審的 FDA 批準新藥評估，結論由專家達成共識

有關先前批準藥物的新信息，包括關鍵臨床試驗、新適應癥和安全警告

常見疾病首選和替代治療的共識建議

針對特定適應癥的藥物進行比較性評價，特別關注臨床療效、不良反應、藥物相互作用和成本。

Medical Letter On Drugs And Therapeutics創刊于1959年，由Medical Letter Inc.出版商出版，收稿方向涵蓋醫學 - 藥學全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發表機率較高。平均審稿速度 較慢,6-12周 ，影響因子指數1.4，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。